Figure 2.

Effect ofBifidobacterium infantis-mediated pTRKH2-PsT/sKDR delivery system on HUVECs. 1: negative control; 2: VEGF; 3: VEGF and final solution of Bifidobacterium infantis transformed with pTRKH2-PsT plasmid; 4: VEGF and final solution of Bifidobacterium infantis transformed with recombinant pTRKH2-PsT/sKDR plasmid.*P < 0.05 vs. VEGF group; P < 0.05 vs. negative control.

Li et al. BMC Cancer 2012 12:155   doi:10.1186/1471-2407-12-155
Download authors' original image